Five studies that compared the performance of GDF-15 and FGF-21 as diagnostic biomarkers for mitochondrial myopathy all showed higher sensitivity of the former [69,70,71,104,105], three also allocated higher specificity to GDF-15 [69,104,105]. This evidence concerns the gene FGF21 and Mitochondrial myopathy.